BriaCell Therapeutics Analyst Ratings
BenzingaDec 28, 2023 11:27 ET
H.C. Wainwright Keeps a Buy Rating on BriaCell Therapeutics (BCT)
TipRanksNov 30, 2023 11:00 ET
BriaCell Therapeutics (BCT) Gets a Buy Rating From H.C. Wainwright
TipRanksOct 27, 2023 06:21 ET
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Lowers Price Target to $20
BenzingaOct 3, 2023 12:03 ET
BriaCell Therapeutics Analyst Ratings
BenzingaOct 3, 2023 12:01 ET
BriaCell Therapeutics (BCT) Initiated With a Buy at H.C. Wainwright
TipRanksOct 3, 2023 11:30 ET
BriaCell Therapeutics (BCT) Initiated With a Buy at H.C. Wainwright
TipRanksSep 8, 2023 12:10 ET
BriaCell Therapeutics (BCT) Gets a Buy Rating From H.C. Wainwright
TipRanksJun 28, 2023 06:20 ET
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target
BenzingaJun 28, 2023 06:12 ET
BriaCell Therapeutics Analyst Ratings
BenzingaFeb 24, 2023 06:38 ET
No Data
No Data